Magnetic drug targeting is a method by which magnetic drug carriers in the body are
manipulated by external magnetic fields to reach the target area. This method is potentially …

Brain tumors are a diverse group of neoplasms that often carry a poor prognosis for patients.
Despite tremendous efforts to develop diagnostic tools and therapeutic avenues, the …

The effective treatment of malignant brain glioma is hindered by the poor transport across
the blood–brain barrier (BBB) and the low penetration across the blood-tumor barrier (BTB) …

The delivery of drugs to a target site frequently involves crossing biological barriers. The
degree and nature of the impediment to flux, as well as the potential approaches to …

Offering the latest information in magnetic nanoparticle (MNP) research, Magnetic
Nanoparticles: From Fabrication to Clinical Applications provides a comprehensive review …

Delivery of therapeutic or diagnostic agents across an intact blood–brain barrier (BBB)
remains a major challenge. Here we demonstrate in a mouse model that magnetic …

Magnetic-based systems utilizing superparamagnetic nanoparticles and a magnetic field
gradient to exert a force on these particles have been used in a wide range of biomedical …

The principle of magnetic drug targeting, wherein therapy is attached to magnetically
responsive carriers and magnetic fields are used to direct that therapy to disease locations …

Background T lymphocytes are highly dynamic elements of the immune system with a tightly
regulated migration. T cell-based transfer therapies are promising therapeutic approaches …

Regenerative medicine, which replaces or regenerates human cells, tissues or organs, to
restore or establish normal function, is one of the fastest-evolving interdisciplinary fields in …